Cited by CrossRef (35)
- Hyun-Lim Kim, Hana Ra, Ki-Ryeong Kim, Jeong-Min Lee, Hana Im, Yang-Hee Kim. Poly(ADP-ribosyl)ation of p53 Contributes to TPEN-Induced Neuronal Apoptosis. 2015;38:312

- Chao Liu, Aditi Vyas, Muzaffer A. Kassab, Anup K. Singh, Xiaochun Yu. The role of poly ADP-ribosylation in the first wave of DNA damage response. 2017;45:8129

- Sabine Hombach‐Klonisch, Forouh Kalantari, Manoj Reddy Medapati, Suchitra Natarajan, Sai Nivedita Krishnan, Aditya Kumar‐Kanojia, Thatchawan Thanasupawat, Farhana Begum, Fred Y. Xu, Grant M. Hatch, Marek Los, Thomas Klonisch. HMGA2 as a functional antagonist of PARP1 inhibitors in tumor cells. Molecular Oncology 2019;13:153

- Pamlea N. Brady, Anupam Goel, Margaret A. Johnson. Poly(ADP-Ribose) Polymerases in Host-Pathogen Interactions, Inflammation, and Immunity. Microbiol Mol Biol Rev 2019;83

- Haoxiu Sun, Chao Liu, Fang Han, Xiaoyu Lin, Liangyu Cao, Chenxing Liu, Qiuyu Ji, Jinjin Cui, Yuanfei Yao, Bojun Wang, Yuanyu liao, Huan Nie, Yanqiao Zhang, Yu Li. The regulation loop of MARVELD1 interacting with PARP1 in DNA damage response maintains genome stability and promotes therapy resistance of cancer cells. Cell Death Differ 2023;30:922

- Cecilia G. Sanchez. Circadian Rhythms and Their Impact on Aging. 2023.

- Nathan A Berger, Valerie C Besson, A Hamid Boulares, Alexander Bürkle, Alberto Chiarugi, Robert S Clark, Nicola J Curtin, Salvatore Cuzzocrea, Ted M Dawson, Valina L Dawson, György Haskó, Lucas Liaudet, Flavio Moroni, Pál Pacher, Peter Radermacher, Andrew L Salzman, Solomon H Snyder, Francisco Garcia Soriano, Robert P Strosznajder, Balázs Sümegi, Raymond A Swanson, Csaba Szabo. Opportunities for the repurposing of PARP inhibitors for the therapy of non‐oncological diseases. British J Pharmacology 2018;175:192

- Nan Li, Lin Feng, Hui Liu, Jiadong Wang, Moses Kasembeli, My Kim Tran, David J. Tweardy, Steven Hsesheng Lin, Junjie Chen. PARP Inhibition Suppresses Growth of EGFR-Mutant Cancers by Targeting Nuclear PKM2. Cell Reports 2016;15:843

- Seon‐gyeong Lee, Namwoo Kim, Su‐min Kim, In Bae Park, Hyejin Kim, Shinseog Kim, Byung‐gyu Kim, Jung Me Hwang, In‐Joon Baek, Anton Gartner, Jun Hong Park, Kyungjae Myung.
Ewing sarcoma protein promotes dissociation of poly(
ADP
‐ribose) polymerase 1 from chromatin
. EMBO Reports 2020;21

- Guillaume Bordet, Niraj Lodhi, Danping Guo, Andrew Kossenkov, Alexei V. Tulin. Poly(ADP-ribose) polymerase 1 in genome-wide expression control in Drosophila. Sci Rep 2020;10

- Davide Alessandro Basello, Anna Ivana Scovassi. Poly(ADP-ribosylation) and neurodegenerative disorders. Mitochondrion 2015;24:56

- Nan Li, Yifan Wang, Weiye Deng, Steven H. Lin. Poly (ADP-Ribose) Polymerases (PARPs) and PARP Inhibitor-Targeted Therapeutics. ACAMC 2019;19:206

- Guillaume Bordet, Alexei V. Tulin. Poly(ADP-Ribose) Polymerase. 2019.

- Haiying Wang, Liqian Yang, Minghui Liu, Jianyuan Luo. Protein post-translational modifications in the regulation of cancer hallmarks. Cancer Gene Ther 2023;30:529

- Yaroslava Karpova, Danping Guo, Peter Makhov, Adam Haines, Dmitriy Markov, Vladimir Kolenko, Alexei Tulin. Poly(ADP)-Ribosylation Inhibition: A Promising Approach for Clear Cell Renal Cell Carcinoma Therapy. Cancers 2021;13:4973

- Jie Zhang, Yuqi Gao, Zipeng Zhang, Jinbo Zhao, Wenshuang Jia, Chengcai Xia, Fugang Wang, Tingting Liu. Multi-therapies Based on PARP Inhibition: Potential Therapeutic Approaches for Cancer Treatment. J. Med. Chem. 2022;65:16099

- Bruce L Martin. eLS. 2022.

- Rebecca L. Farr, Celien Lismont, Stanley R. Terlecky, Marc Fransen. Peroxisome biogenesis in mammalian cells: The impact of genes and environment. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2016;1863:1049

- Haritha Kunhiraman, Vishnu Ramachandran, Lincy Edatt, V. B. Sameer Kumar. Regulation of poly ADP-ribosylation of VEGF by an interplay between PARP-16 and TNKS-2. Mol Cell Biochem 2020;471:15

- Mykhailo M. Guzyk, Artem A. Tykhomyrov, Victor S. Nedzvetsky, Irina V. Prischepa, Tatiana V. Grinenko, Lesya V. Yanitska, Tamara M. Kuchmerovska. Poly(ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors Reduce Reactive Gliosis and Improve Angiostatin Levels in Retina of Diabetic Rats. Neurochem Res 2016;41:2526

- Hanah Rodriguez, Haloom Rafehi, Mrinal Bhave, Assam El-Osta. Metabolism and chromatin dynamics in health and disease. Molecular Aspects of Medicine 2017;54:1

- Guanyi Zhang, Zemin Wang, Jasmin Bavarva, Katherine J. Kuhns, Jianhui Guo, Elisa M. Ledet, Chiping Qian, Yuan Lin, Zhide Fang, Jovanny Zabaleta, Luis Del Valle, Jennifer J. Hu, Diptasri Mandal, Wanguo Liu. A Recurrent ADPRHL1 Germline Mutation Activates PARP1 and Confers Prostate Cancer Risk in African American Families. 2022;20:1776

- Yaroslava Karpova, Sarah J. Johnson, Guillaume Bordet, Danping Guo, Atreyi Ghatak, Dmitriy A. Markov, Alexei V. Tulin. Upregulation of PARG in prostate cancer cells suppresses their malignant behavior and downregulates tumor-promoting genes. Biomedicine & Pharmacotherapy 2022;153:113504

- Tim P Levine. Sequence Analysis and Structural Predictions of Lipid Transfer Bridges in the Repeating Beta Groove (RBG) Superfamily Reveal Past and Present Domain Variations Affecting Form, Function and Interactions of VPS13, ATG2, SHIP164, Hobbit and Tweek. Contact 2022;5:251525642211343

- Min Kyung Lee, Hyun Sub Cheong, Youngil Koh, Kwang-Sung Ahn, Sung-Soo Yoon, Hyoung Doo Shin. Genetic Association ofPARP15Polymorphisms with Clinical Outcome of Acute Myeloid Leukemia in a Korean Population. Genetic Testing and Molecular Biomarkers 2016;20:696

- Anna De Maio, Elena Porzio, Sergio Rotondo, Anna Rita Bianchi, Maria Rosaria Faraone-Mennella. In Sulfolobus solfataricus, the Poly(ADP-Ribose) Polymerase-Like Thermoprotein Is a Multifunctional Enzyme. Microorganisms 2020;8:1523

- Yuying He, Qiong Wang, Jian Li, Zhaoxia Li. Comparative proteomic profiling in Chinese shrimp Fenneropenaeus chinensis under low pH stress. Fish & Shellfish Immunology 2022;120:526

- Qian Chen, Kai Ma, Xiuhua Liu, Shih-Hsun Chen, Peng Li, Yonghao Yu, Anthony K. L. Leung, Xiaochun Yu. Truncated PARP1 mediates ADP-ribosylation of RNA polymerase III for apoptosis. Cell Discov 2022;8

- Lucie Vaufrey, Arun Prasath Damodaran, Olivia Gavard, Stéphanie Le Bras, Claude Prigent. Protein Phosphorylation. 2022.

- Anna Maggiore, Assunta Maria Casale, Walter Toscanelli, Ugo Cappucci, Dante Rotili, Maddalena Grieco, Jean-Philippe Gagné, Guy G. Poirier, Maria d’Erme, Lucia Piacentini. Neuroprotective Effects of PARP Inhibitors in Drosophila Models of Alzheimer’s Disease. Cells 2022;11:1284

- Guillaume Bordet, Gbolahan Bamgbose, Sayem H. Bhuiyam, Sarah Johnson, Alexei V. Tulin. Poly(ADP-Ribose) Polymerase. 2022.

- Harald Lahm, Meiwen Jia, Martina Dreßen, Felix Wirth, Nazan Puluca, Ralf Gilsbach, Bernard D. Keavney, Julie Cleuziou, Nicole Beck, Olga Bondareva, Elda Dzilic, Melchior Burri, Karl C. König, Johannes A. Ziegelmüller, Claudia Abou-Ajram, Irina Neb, Zhong Zhang, Stefanie A. Doppler, Elisa Mastantuono, Peter Lichtner, Gertrud Eckstein, Jürgen Hörer, Peter Ewert, James R. Priest, Lutz Hein, Rüdiger Lange, Thomas Meitinger, Heather J. Cordell, Bertram Müller-Myhsok, Markus Krane. Congenital heart disease risk loci identified by genome-wide association study in European patients. 2021;131

- Mincheol Kang, Seojin Park, Seong-Hoon Park, Hee Gu Lee, Jun Hong Park. A Double-Edged Sword: The Two Faces of PARylation. IJMS 2022;23:9826

- Kaishun Hu, Wenjing Wu, Yu Li, Lehang Lin, Dong Chen, Haiyan Yan, Xing Xiao, Hengxing Chen, Zhen Chen, Yin Zhang, Shuangbing Xu, Yabin Guo, H Phillip Koeffler, Erwei Song, Dong Yin.
Poly(
ADP
‐ribosyl)ation of
BRD
7 by
PARP
1 confers resistance to
DNA
‐damaging chemotherapeutic agents
. EMBO Reports 2019;20

- Nan Li, Yifan Wang, Shinya Neri, Yuanli Zhen, Lon Wolf R. Fong, Yawei Qiao, Xu Li, Zhen Chen, Clifford Stephan, Weiye Deng, Rui Ye, Wen Jiang, Shuxing Zhang, Yonghao Yu, Mien-Chie Hung, Junjie Chen, Steven H. Lin. Tankyrase disrupts metabolic homeostasis and promotes tumorigenesis by inhibiting LKB1-AMPK signalling. Nat Commun 2019;10
